Home
Toolbox
Resource
Workflow
Tutorials
Citations
Downloads
Mutation Al-Predictor Flow
Gene-to-Mutation Flow
News & Insights
Genetic Encyclopedia
Frontiers
Industry Insights
Case Studies
About Us
About the Site
Contact Us
Private Policy
User Agreement
COL4A5 c.1390G>A
ALS1
DMD c.1332-11868C>G
TP53
肌萎缩侧索硬化症1型
USH2A c.8559-2A>G
囊性纤维化
Log In
|
Sign Up
中文
非罕见病
Suppression of Tumorigenicity 12 (ST12)
Alias:
Prostate Adenocarcinoma
Adenocarcinoma of Prostate
Prostate Adenocarcinoma 1
St12
Pac1
Create a favorites folder
Cancel
Confirm
Add To Favorites
Select a favorites
Description
New favorites >>
Cancel
Confirm
Favorite
基础信息
疾病表征
基因 & 突变
靶点药物
疾病模型
文献报道
抑制肿瘤性12,也称为前列腺腺癌,与腺癌和前列腺癌有关。与抑制肿瘤性12有关的重要基因是KLF6(KLF转录因子6),其相关通路/超通路包括基因表达(转录)和传染病。在该疾病的背景下提到了普鲁卡因和利多卡因。附属组织包括前列腺和淋巴结,相关表型为活力降低和细胞迁移增加。
Related ID:
MALACARDS:SPP011
OMIM:601188
ICD11:1510677183
Basic Information
Inheritance
Age of Onset
Prevalence
Related Gene
Related Mouse Models
Reference
MALACARDS
--
未知
--
52
829
2
SPP011
Medical Symptom
#
Categorization
Description
HPO Frequency
Orphanet Frequency
HPO Source Accession
No data available
Gene & Mutation
#
Gene
Function
Score
Mutations
No data available
Related Drugs
Name
CAS Number
Status
Phase
No data available
Disease Model
Category
Name
MGI
Related Gene
Strain of Origin
Publications
No data available
References Literature
Title
PMID
Journal
Year
IF
No Data Found!
微信
信息比对
科研助手
使用教程
回到顶部